
Sign up to save your podcasts
Or
In episode 35 we discuss whether eliminating prior auths leads to more buprenorphine prescribing.
Christine PJ, Larochelle MR, Lin L, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023;4(10):e233549.
We also discuss buprenorphine diversion, and the lack of treatments for stimulant use disorder.
Harm Reduction Journal: Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study
NBC news: Why are there no treatments for cocaine and meth addiction?
----------
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, please visit MI CARES.
----------
Episode 35 Credits:
----------
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.9
3030 ratings
In episode 35 we discuss whether eliminating prior auths leads to more buprenorphine prescribing.
Christine PJ, Larochelle MR, Lin L, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023;4(10):e233549.
We also discuss buprenorphine diversion, and the lack of treatments for stimulant use disorder.
Harm Reduction Journal: Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study
NBC news: Why are there no treatments for cocaine and meth addiction?
----------
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, please visit MI CARES.
----------
Episode 35 Credits:
----------
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
133 Listeners
3,318 Listeners
1,090 Listeners
29 Listeners
1,321 Listeners
714 Listeners
183 Listeners
285 Listeners
512 Listeners
548 Listeners
362 Listeners
42 Listeners
121 Listeners
8 Listeners
112 Listeners